Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) EPS (Weighted Average and Diluted) (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed EPS (Weighted Average and Diluted) for 14 consecutive years, with -$1.54 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, EPS (Weighted Average and Diluted) fell 151.68% year-over-year to -$1.54, compared with a TTM value of -$1.68 through Sep 2025, up 63.6%, and an annual FY2025 reading of -$2.13, changed N/A over the prior year.
  • EPS (Weighted Average and Diluted) was -$1.54 for Q2 2025 at SRx Health Solutions, down from -$0.37 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $2.98 in Q2 2024 and bottomed at -$58.42 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$5.35, with a median of -$0.88 recorded in 2021.
  • The sharpest move saw EPS (Weighted Average and Diluted) crashed 29110.0% in 2022, then soared 169.79% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.2 in 2021, then plummeted by 29110.0% to -$58.42 in 2022, then skyrocketed by 64.32% to -$20.85 in 2023, then skyrocketed by 99.18% to -$0.17 in 2024, then tumbled by 805.88% to -$1.54 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for SRXH at -$1.54 in Q2 2025, -$0.37 in Q1 2025, and -$0.17 in Q4 2024.